Nicole Bizzell
Family · Warner Robins, GANPI 1013101443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 291 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$710
- Amgen$623
- Johnson & Johnson$461
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$438
- Lilly USA, LLC$300
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,73496%
- Education$2564%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $1,242 |
| AstraZeneca | 30 | $710 |
| Amgen | 36 | $623 |
| Johnson & Johnson(2 entities) | 8 | $461 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $438 |
| Lilly USA, LLC | 19 | $300 |
| Boehringer Ingelheim | 15 | $266 |
| Pfizer | 13 | $263 |
| Paratek Pharmaceuticals, Inc. | 9 | $194 |
| AbbVie | 11 | $182 |
| Esperion Therapeutics, Inc. | 9 | $158 |
| Astellas Pharma US Inc | 3 | $135 |
| Antares Pharma, Inc. | 7 | $131 |
| Abbott | 4 | $85 |
| Exact Sciences | 4 | $70 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $68 |
| GSK | 3 | $65 |
| Novartis | 4 | $64 |
| Idorsia Pharmaceuticals US Inc | 3 | $63 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Merck | 3 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| Tolmar, Inc. | 2 | $40 |
| Dexcom, Inc. | 2 | $35 |
| Boston Scientific | 1 | $34 |
| IBSA Pharma Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Redhill Biopharma Inc. | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Halozyme Inc | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Biogen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,990 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 28 | $36,101 |
| EliquisApixaban | 37 | $34,725 |
| JardianceEmpagliflozin | 27 | $26,737 |
| JanuviaSitagliptin Phosphate | 12 | $14,587 |
| MounjaroTirzepatide | 15 | $14,531 |
| PremarinEstrogens, Conjugated | 11 | $3,822 |
| Levothyroxine Sodium | 206 | $1,906 |
| Valsartan | 18 | $1,561 |
| Atorvastatin Calcium | 185 | $1,556 |
| Rosuvastatin Calcium | 104 | $1,278 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,246 |
| Sucralfate | 12 | $1,134 |
| Ezetimibe | 41 | $1,123 |
| Fluticasone Propionate | 64 | $1,037 |
| Duloxetine Hcl | 34 | $872 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin | $263 | $38,54748 claims |
| Novo NordiskOzempic | $1,242 | $36,10128 claims |
| Boehringer IngelheimJardiance | $266 | $26,73727 claims |
| MerckJanuvia | $57 | $14,58712 claims |
| Lilly USA, LLCMounjaro | $300 | $14,53115 claims |
| AbbVieSynthroid | $182 | $81417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Warner Robins
- Kelly MurrayWarner Robins$18K
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.